MedPath

Fludrocortisone Acetate

FLUDROCORTISONE ACETATE TABLETS, USP(0.1 mg)

Approved
Approval ID

3c007f9a-4cd5-4e74-a633-d55dde1fe903

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 17, 2020

Manufacturers
FDA

NCS HealthCare of KY, Inc dba Vangard Labs

DUNS: 050052943

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

FLUDROCORTISONE ACETATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0615-6562
Application NumberANDA040431
Product Classification
M
Marketing Category
C73584
G
Generic Name
FLUDROCORTISONE ACETATE
Product Specifications
Route of AdministrationORAL
Effective DateNovember 3, 2020
FDA Product Classification

INGREDIENTS (5)

FLUDROCORTISONE ACETATEActive
Quantity: 0.1 mg in 1 1
Code: V47IF0PVH4
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fludrocortisone Acetate - FDA Drug Approval Details